Dr. Mark Packer MD
Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
Member of the Healthcare Council
Council Member Biography
Mark Packer, MD, FACS, CPI is a Clinical Associate Professor of Ophthalmology at Oregon Health & Sciences University and Managing Partner at Drs. Fine, Hoffman, Packer & Sims in Eugene, Oregon. Dr. Packer's clinical research focuses on refractive cataract surgery, intraocular lens technology and glaucoma surgical devices. He served as Principal Investigator and Medical Monitor for the US FDA study of the Tecnis Multifocal Aspheric Intraocular Lens, and was Principal Investigator for the Visiogen Synchrony Dual Optic Accommodative Lens. He is currently the Medical Monitor for Transcend Medical's CyPass glaucoma shunt, Bausch & Lomb's enVista Intraocular Lens and TrueVision's 3D High Definition System for Surgical Guidance. He is also a Principal Investigator for Calhoun's Light Adjustable Lens. He works extensively with leaders in the ophthalmic industry on the development of new technology for cataract and refractive surgery. Dr. Packer is a consultant to Abbott Medical Optics, Advanced Vision Science, Allergan, Bausch & Lomb, Corinthian Ophthalmic, GE Health Care, Ista Pharmaceuticals, LensAR, mTuitive, NewSee, Rayner Intraocular Lenses, Surgiview, Transcend Medical, TrueVision Systems, VisionCare Ophthalmic Technologies and WaveTec Vision Systems. (This is me - Update Profile)
Employment History
- 2001 - Unspecified
- Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
- 2000 - Unspecified
- Managing Partner , DR'S FINE HOFFMAN & PACKER LLC
GLG NewsSM Analyses by Mark Packer
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
FDA Panel votes for safety, effectiveness for the Glaukos iStent.
December 11, 2010
FDA Ophthalmic Device Panel Meeting, July 30, 2010 | www.fdalive.com
On July 30, 2010, the Ophthalmic Devices Panel reviewed data for the iStent, a trabecular micro-bypass shunt from Glaukos Corporation. The Panel voted 7 – 1 that there is a reasonable assurance of safety, 6 – 2 that there is a reasonable assurance of effectiveness, and 7 – 1 that there is a favorable risk/benefit ratio. At the end of the day, it was the perspective of two glaucoma subspecialists sitting on the Panel, Eve Higginbotham and Anne Coleman, that carried the greatest weight.
-
Femtosecond Lasers Come to Cataract Surgery
March 26, 2010
Femtosecond laser cataract surgery | bmctoday.net
Cataract surgeons are impelled by their inward drive towards perfection to love the possibilities that femtosecond phaco creates. This technology changes everything. The pioneers of phaco, and the surgical techniques they developed that are still in use today, are coming to appear as the devices of medieval artisans relative to the streamlined accuracy of a nascent industrial era.
-
Digital 3D HD Imaging Gains Traction in the Ophthalmic OR
February 21, 2010
TrueVision Systems Releases First Ever 3D Visualization and Guidance Platform for Microsurgery | www.microscopy-news.com
There are tremendous applications for 3D HD surgery in ophthalmology, from education to archiving to enhancing surgical outcomes. As this technology moves forward through incision marking and toric intraocular lens placement with the Ophthalmic Tool Set, the capabilities of 3D surgery will surpass what we have in the standard microscope.
-
December 17, 2009
Optonol: Reaping $180m from a device the size of a grain of rice | www.haaretz.com
Alcon, the U.S. eye care pharmaceuticals and devices giant, announced this week that it will acquire Optonol, an Israeli company that manufactures the Ex-PRESS glaucoma mini-shunt. This innovative shunt has demonstrated good results in the reduction of intraocular pressure, with investigators reporting about 95% success at 3 years (http://community.modernmedicine.com/_Growing-Glaucoma-ProceduresECP-and-the-Ex-PRESS-Shunt/blog/439235/33379.html).
-
WaveTec's ORange Aberrometer Enhances Correction of Astigmatism
December 8, 2009
Intraoperative wavefront aberrometry valuable for enhancing LRI outcomes | www.flipleaf.com
ORange (WaveTec Vision) constitutes the first-ever ability to conveniently perform refraction measurements on patients during cataract surgery itself. The device is mounted directly beneath the surgeon’s operating microscope and measurements are taken in the same co-axial line of sight used to visualize the eye and perform surgery. The software provides refraction readings following limbal relaxing incisions that allow physicians to further optimize the Limbal Relaxing Incisions and reduce remaining astigmatism.
GLG Study Groups with Mark Packer(?)
| Study Group Name | No. Members |
|---|---|
| Ophthalmologists | 1707 |
| Ophthalmologists (US) | 1196 |
| Corneal and Refractive Ophthalmic Surgeons (US) | 541 |
| Refractive Surgeons (US) | 325 |
| Physicians who Implant Intraocular Lenses | 248 |
GLG Live Meetings with Mark Packer(?)
Mark Packer has not participated in any GLG Live Meetings.
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.